<- Go Home

Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States.

Market Cap

$510.1M

Volume

999.4K

Cash and Equivalents

$616.2M

EBITDA

-$477.3M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$176.4M

Profit Margin

80.94%

52 Week High

$75.20

52 Week Low

$5.26

Dividend

N/A

Price / Book Value

0.64

Price / Earnings

-0.75

Price / Tangible Book Value

0.71

Enterprise Value

$339.5M

Enterprise Value / EBITDA

-0.86

Operating Income

-$538.6M

Return on Equity

-63.51%

Return on Assets

-19.19

Cash and Short Term Investments

$616.2M

Debt

$445.6M

Equity

$797.9M

Revenue

$218.0M

Unlevered FCF

-$195.7M

Sector

Chemicals

Category

N/A

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches